This activity will explore updated approaches to the management of glaucoma—the “silent thief of sight” that affects an estimated 3 million Americans. It will examine the latest evidence from recent studies on minimally invasive glaucoma surgery (MIGS) procedures and discuss comparative data on more invasive surgical techniques such as trabeculectomy and tube shunt surgery. Patient cases will be introduced to enhance participants’ understanding of the glaucoma treatment process. In addition, potential future innovations in glaucoma treatment will be discussed.

Bladder cancer (BC) is the tenth most common cancer worldwide, and its associated five-year survival rate declines rapidly (from 96% to 6%) as it progresses from in situ through local invasion, regional spread and finally to distal spread. Thus, early detection and timely therapeutic interventions are crucial to improve outcomes and reduce the burden of disease. Outcomes have been further improved by the integration of recently approved therapies for BC, the utilization of biomarkers to guide treatment plans and the opportunity for eligible patients with BC to enroll in clinical trials. For all treatment plans, effective communication among the health care team is crucial for providing comprehensive care for this condition. This activity will provide participants with an overview of early BC diagnosis and its impact on survival rates. It will explore recently approved therapies for BC both as standalone treatments and in combination with established therapeutic approaches. Emerging therapies and their potential benefits will be examined, and the value of biomarkers will be discussed. Participants will gain insight into treatment strategies to optimize patient outcomes in BC.

Clinical practice guidelines are used in health care as an educational tool to improve patient care as a potential solution to reduce inappropriate variations in care. Opioid prescribing guidelines provide clear and comprehensive, evidence-based recommendations incorporating current information and practices for practitioners. This activity will examine the scope, impact, key statistics and factors contributing to the opioid crisis and highlight the current recommended opioid prescribing guidelines, their challenges and the role of state prescription drug monitoring programs (PDMP). Strategies to aid in implementing the opioid prescribing guidelines and to mitigate the opioid crisis will also be discussed.

Urinary tract infections (UTIs) are the most common infectious illness, particularly among individuals aged 65 years and older, and affect roughly 20% to 35% of women during their lifetime. UTIs contribute to 8 million ambulatory visits and 1 million hospitalizations annually in the US. This podcast will provide an overview of updated approaches to UTI detection, diagnosis and treatment; review common uropathogens; and highlight the distinctive challenges of UTIs related to infection characteristics and complications. Experts will share valuable insights through a discussion of evidence-based strategies to manage and prevent UTIs effectively.